Close Menu

MIT researcher Mark Bear says that biotechs hold the key to treating autism and some forms of mental retardation, with the drugs that are already on their lab shelves, says the Forbes Treatments blog's Robert Langreth. Bear's "radical" new theory suggest that a specific class of drug already developed by drug companies may help patients with an inherited disease, fragile X syndrome, which is thought to be a cause of autism.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In a letter, about two dozen researchers criticize the World Health Organization investigation into the origins of SARS-CoV-2 and call for a new inquiry, the Wall Street Journal reports.

National Geographic reports that nine great apes at the San Diego Zoo have been vaccinated against SARS-CoV-2.

Janet Woodcock, the acting commissioner of the US Food and Drug Administration, speaks with NPR about SARS-CoV-2 testing and vaccines in the US.

In Science this week: genetic study of kidney fibrosis implicates the SOX9-NAV3-YAP1 axis.